Spina Bifida Treatment Market
Global Spina Bifida Treatment Market Size, Share & Trends Analysis Report, by Type (Occulta, Closed neural tube defects, Meningocele, and Myelomeningocele), by Treatment (Surgery {Cesarean section, Suprapubic cystostomy, Spinal Surgery, Colostomy, and Others}, Medical Procedure {Urinary catheterization, Urinary diversion, Enema}, and Devices) and Forecast Period 2019-2025 Update Available - Forecast 2024-2030
The global spina bifida treatment market is estimated to grow at a CAGR of around 7% during the forecast period. Spina bifida is a type of birth defect that happens to infants when the spine and spinal cord don't form properly. Spina bifida is a type of neural tube defect. This defect happens to a developing baby, while in the womb when the spinal cord fails to develop or close properly. Spina bifida symptoms can be seen on the skin above the spinal defect. It can range from mild to serve, and it depends on the type of defect, size, location, and complications.
Growing cases of spina bifida among the infants and medical advancement are driving the growth of the global spina bifida treatment market. For instance, as per the Center for Disease Control and Prevention (CDC) each year, in the US, about 1,645 babies are born with spina bifida. During 2006-2015, in China, a total of 2,029 cases of spina bifida were identified. Moreover, growing awareness, increasing government assistance, and rising funding and reimbursement are propelling the growth of the market.
High cost involved in spina bifida treatment is restraining the global spina bifida treatment market growth. According to the National Center for Biotechnology Information (NCBI), the estimated lifetime cost of care for a person with spina bifida, with caregiving costs, is $791,900. A study from 2013 showed that hospitalizations related to birth defects of the brain and spine (including spina bifida) cost more than $1.6 billion in 2013 for people of all ages, data were collected from Healthcare Cost and Utilization Project (HCUP) and 2013 National Inpatient Sample.
Beside it, new technological innovations in the spina bifida treatment market is an opportunity factor in the global spina bifida treatment market. For instance, in September 2019, the National Institute for Health and Care Excellence (NICE) talked about two techniques of spina bifida treatment, the first consisted of opening the womb through surgery and operating on the fetus, and the other involved using keyhole surgery to access the unborn baby. Such advancement in technology is expected to boost market growth in the near future.
Market Segmentation
The global spina bifida treatment market is segmented based on type and treatment. Based on the type, the market is segmented into occulta, closed neural tube defects, meningocele, and myelomeningocele. And based on the treatment, the market is segmented into surgery, medical procedures, and devices. Furthermore, based on the surgery, the market is further segmented into the cesarean section, suprapubic cystostomy, spinal surgery, colostomy, and others. Based on the medical procedure, the market is segmented into urinary catheterization, urinary diversion, enema.
Myelomeningocele held a significant share in the market
Myelomeningocele is the most common and serious type of spina bifida. In this defect, the spinal cord and nerves develop outside of the body. This can result in muscle weakness or paralysis, bowel and bladder problems, hydrocephalus, Chiari Malformation, seizures, and orthopedic conditions such as scoliosis, hip problems, and foot deformities. In most of the cases, myelomeningocele is treated by surgery after birth.
Global Spina Bifida Treatment Market Share by Type, 2018 (%)
Regional Outlook
Geographically, the market is segmented on the basis of the region that includes North America, Europe, Asia-Pacific, and the rest of the world. North America is expected to have a significant market share in the global spina bifida treatment market. Key factors that are driving the market are the availability of proper healthcare infrastructures and the presence of the major players offering innovative spina bifida treatment procedures in the market. Moreover, the Asia-Pacific region is the fastest-growing spina bifida treatment market owing to large numbers of the patient and increasing health awareness.
Global Spina Bifida Treatment Market Growth, by Region 2019-2025
Competitive Landscape
The major players providing spina bifida treatment that include Medtronic PLC, Boston Scientific Corp., Karl Storz SE & Co. KG, Johnson & Johnson Service, Inc., Zimmer Biomet Holdings, Inc., NuVasive, Inc, Smith & Nephew PLC, Stryker Corp., and Wellspect Healthcare (A Dentsply Sirona Company). Range of spina bifida treatment equipment manufactured by these key players including Ennovate, Aesculap XP, Elan 4, Aesculap Aeos, and others.
The Report Covers
- Market value data analysis of 2018 and forecast to 2025.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the global spina bifida treatment market. Based on the availability of data, information related to pipeline products, and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusions
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Medtronic PLC
3.3.1.1. Overview
3.3.1.2. Financial Analysis
3.3.1.3. SWOT Analysis
3.3.1.4. Recent Developments
3.3.2. Boston Scientific Corp.
3.3.2.1. Overview
3.3.2.2. Financial Analysis
3.3.2.3. SWOT Analysis
3.3.2.4. Recent Developments
3.3.3. Karl Storz SE & Co. KG
3.3.3.1. Overview
3.3.3.2. Financial Analysis
3.3.3.3. SWOT Analysis
3.3.3.4. Recent Developments
3.3.4. Johnson & Johnson Service, Inc.
3.3.4.1. Overview
3.3.4.2. Financial Analysis
3.3.4.3. SWOT Analysis
3.3.4.4. Recent Developments
3.3.5. Zimmer Biomet Holdings, Inc.
3.3.5.1. Overview
3.3.5.2. Financial Analysis
3.3.5.3. SWOT Analysis
3.3.5.4. Recent Developments
4. Market Determinants
4.1 Motivators
4.2 Restraints
4.3 Opportunities
5. Market Segmentation
5.1. Global Spina Bifida Treatment Market by Type
5.1.1. Occulta
5.1.2. Closed neural tube defects
5.1.3. Meningocele
5.1.4. Myelomeningocele
5.2. Global Spina Bifida Treatment Market by Treatment
5.2.1. Surgery
5.2.1.1. Cesarean section
5.2.1.2. Suprapubic cystostomy
5.2.1.3. Spinal Surgery
5.2.1.4. Colostomy
5.2.1.5. Others
5.2.2. Medical Procedure
5.2.2.1. Urinary Catheterization
5.2.2.2. Urinary Diversion
5.2.2.3. Enema
5.2.3. Devices
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. B. Braun Melsungen AG
7.2. Boston Scientific Corp.
7.3. C.R. Bard, Inc. (Becton, Dickinson and Co.)
7.4. Coloplast A/S
7.5. ConvaTec Group PLC
7.6. Cook Medical, Inc.
7.7. Johnson & Johnson Service, Inc.
7.8. Karl Storz SE & Co. KG
7.9. Medtronic PLC
7.10. NuVasive, Inc.
7.11. Smith & Nephew PLC
7.12. Stryker Corp.
7.13. Teleflex, Inc.
7.14. Wellspect Healthcare (A Dentsply Sirona Company)
7.15. Zimmer Biomet Holdings, Inc.
1. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
2. GLOBAL OCCULTA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
3. GLOBAL CLOSED NEURAL TUBE DEFECTS MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
4. GLOBAL MENINGOCELE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
5. GLOBAL MYELOMENINGOCELE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
6. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
7. GLOBAL SPINA BIFIDA SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
8. GLOBAL CESAREAN SECTION SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
9. GLOBAL SUPRAPUBIC CYSTOSTOMY SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
10. GLOBAL SPINAL SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
11. GLOBAL COLOSTOMY SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
12. GLOBAL OTHER SURGERY MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
13. GLOBAL MEDICAL PROCEDURE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
14. GLOBAL URINARY CATHETERIZATION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
15. GLOBAL URINARY DIVERSION MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
16. GLOBAL ENEMA MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
17. GLOBAL SPINA BIFIDA DEVICE MARKET RESEARCH AND ANALYSIS BY REGION, 2018-2025 ($ MILLION)
18. GLOBAL SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2018-2025 ($ MILLION)
19. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
20. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
21. NORTH AMERICAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
22. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
23. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
24. EUROPEAN SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
25. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2018-2025 ($ MILLION)
26. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
27. ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
28. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TYPE, 2018-2025 ($ MILLION)
29. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET RESEARCH AND ANALYSIS BY TREATMENT, 2018-2025 ($ MILLION)
1. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY TYPE, 2018 VS 2025 (%)
2. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY TREATMENT, 2018 VS 2025 (%)
3. GLOBAL SPINA BIFIDA TREATMENT MARKET SHARE BY GEOGRAPHY, 2018 VS 2025 (%)
4. US SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
5. CANADA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
6. UK SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
7. FRANCE SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
8. GERMANY SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
9. ITALY SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
10. SPAIN SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
11. ROE SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
12. INDIA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
13. CHINA SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
14. JAPAN SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
15. REST OF ASIA-PACIFIC SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
16. REST OF THE WORLD SPINA BIFIDA TREATMENT MARKET SIZE, 2018-2025 ($ MILLION)
